DBV Technologies S.A. (DBVT) vs Verastem, Inc. (VSTM)
DBV Technologies S.A. and Verastem, Inc. are both Biotechnology companies. DBV Technologies S.A. and Verastem, Inc. are of similar size ($734.7M and $694.6M). Verastem, Inc. grew revenue faster over the last twelve months: 472.9% against 27.1%. Verastem, Inc. has the higher net margin (−231.6% vs −3,564.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Verastem, Inc. leads on 9 and DBV Technologies S.A. on 8.
Valuation
Profitability
| Metric | DBVT | VSTM | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 86.35% | 65.16% |
| Operating margin | (3,601.22%) | (182.57%) | 0.00% |
| Net margin | (3,564.57%) | (231.59%) | 0.00% |
| Free cash flow margin | (3,456.50%) | (185.31%) | 0.00% |
| Return on equity | (142.63%) | (471.16%) | (57.72%) |
| Return on assets | (95.98%) | (100.65%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack